Drawing for NORDIC BIOSCIENCE

USPTO serial 79378675

NORDIC BIOSCIENCE

Reviewed by CopyMark Law Group

Reg. 8072442Status 700Registered
Filing date
Status date
Registration date
Dec 23, 2025
Examiner
BIBB, SCOTT
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NORDIC BIOSCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew M. Smith

Andrew M. Smith Resonate IP, LLCP.O. Box 165012 Fulwood PlaceBend, OR 97709

Goods and services

ClassDescriptionStatusFirst use
005diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical useACTIVE—
042custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 28, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 28, 2026FIMPFINAL DISPOSITION PROCESSED—
Mar 23, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 7, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 7, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 7, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 12, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 12, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 5, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 5, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2024RFNTREFUSAL PROCESSED BY IB—
May 10, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 10, 2024RFRRREFUSAL PROCESSED BY MPU—
May 4, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2024RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
May 3, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 2, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2024DOCKASSIGNED TO EXAMINER—
Sep 19, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 14, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance